Today’s Solutions: August 23, 2026

For too long, migraines have been a black spot in medical research. Now sufferers of the condition can have hope after a new antibody treatment developed specifically for migraine prevention has just completed Phase III human clinical trials with remarkably positive results. In the study, respondents reported a 50 percent reduction in monthly migraine days. 

Solutions News Source Print this article
More of Today's Solutions

5 anti-inflammatory spices that aren’t turmeric

Turmeric tends to get all the attention when it comes to anti-inflammatory spices, but don’t overlook these five other spices that functional food expert ...

Read More

The gene that could stop Parkinson’s disease

Scientists are always working tirelessly to figure out new, effective treatments for complex neurological conditions. Here at The Optimist Daily, we’ve reported on many ...

Read More

Meet Susan Murabana, the astronomer bringing the cosmos to Kenyan youth

A celestial display unfolds beneath the velvety African night sky, amidst the peace of Kenya's isolated Samburu county. It’s 1:30 AM in mid-August, and ...

Read More

Unlock your charisma with science-based tips for every personality

BY THE OPTIMIST DAILY EDITORIAL TEAM Charisma may appear to be something you are born with or without, yet research indicates that it is ...

Read More